Article info
Therapeutics
Randomised controlled trial
Closure of a patent foramen ovale with a device does not offer a greater benefit than medical therapy alone for the prevention of recurrent cerebrovascular events
- Correspondence to: Professor Heinrich Mattle
Department of Neurology, Freiburgstrasse, 3010 Bern, Switzerland; heinrich.mattle{at}insel.ch
Citation
Closure of a patent foramen ovale with a device does not offer a greater benefit than medical therapy alone for the prevention of recurrent cerebrovascular events
Publication history
- First published July 10, 2012.
Online issue publication
June 24, 2019
Article Versions
- Previous version (24 June 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions